Novella-Navarro, Marta http://orcid.org/0000-0002-2200-0859
Balsa, Alejandro http://orcid.org/0000-0001-8070-7062
Article History
Accepted: 17 August 2022
First Online: 15 September 2022
Declarations
:
: No funding was received for the preparation of this article.
: Marta Novella-Navarro reports grants from UCB, Galapagos, Lilly and Janssen outside the submitted work. Alejandro Balsa reports grants form Abbvie, Amgen, Pfizer, Galapagos, Novartis, Gilead, BMS, Nordic, Sanofi, Sandoz, Lilly, UCB and Roche outside the submitted work.
: This review article did not require approval by an ethics committee.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: MN-N and AB designed and drafted the work.